Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-22-ERP-RPA: DOD Epilepsy, Research Partnership Award

Closed Closed June 23, 2022 Opportunity W81XWH-22-ERP-RPA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.

• Total funding$1.3 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The intent of the FY22 ERP RPA is to create an avenue to support new or existing collaborative research partnerships between/among investigators to address a research problem or question in a manner that would be unachievable through separate efforts. It is expected that investigators utilize their distinct but complementary perspectives to synergistically address a central problem or question critical to PTE research and those living with PTE, their families, and/or their care partners. Important aspects of this award mechanism include: • Partnership: The FY22 ERP RPA requires that a minimum of two investigators partner in one overarching study. The investigators may have experience in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application. The application should demonstrate how the unique skills and contributions of the Principal Investigator (PI) and Co-PI(s) will support the meaningful and synergistic success of the project. A proposed project in which a partner merely supplies tissue or access to patients will not meet the intent of this award mechanism. • Impact: Applications should articulate the short- and long-term impact of the proposed research on the PTE research field, patient care, and those living with PTE. Projects should address one or more of the FY22 ERP Focus Areas or provide a strong justification as to why the alternative topic is critical to advance understanding of PTE and addresses the ERP mission. Applicants are encouraged to consult with individuals living with PTE during the development and execution of the proposed research project, to ensure research outcomes maximize translational and impact potential. • Relevance to Military Health: Projects must be relevant to military Service Members, their families, and Veterans with PTE. Collaboration with military and VA researchers and clinicians is encouraged. • Experience in PTE Research: The PI and Co-PI(s) on the application can be from any field or discipline; however, it is CRITICAL that the application demonstrate the study team’s experience in PTE research, including expertise in the fields of BOTH TBI and epilepsy. • Preliminary Data: Applications must include preliminary and/or published data that support the proposed research project. Preliminary data may be derived from a laboratory discovery, clinical observation, population-based studies, or from the peer-reviewed literature.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.